Iswarya Hospital launches advanced cancer centre in Chennai

Written By :  Rumela De Sarkar
Published On 2026-03-10 06:09 GMT   |   Update On 2026-03-10 06:09 GMT
Cancer Care

Chennai: In a move aimed at strengthening advanced cancer diagnosis and treatment services, Iswarya Hospital has inaugurated the Iswarya Cancer Centre at its OMR Taramani facility in Chennai. The newly launched centre introduces cutting-edge oncology services, including high-precision radiotherapy, immunotherapy, complex cancer surgeries, and an AI-powered PET-CT scan designed to improve early detection and evaluation of cancer.

According to the news reports, the facility was inaugurated by chief guest Sathyaraj, noted actor and public figure, in the presence of Dr. S. Rajasundaram, Chief Executive Officer of Iswarya Hospital, and Dr. Arun Muthuvel, Managing Director of the hospital, along with members of the multidisciplinary oncology team.

Also Read:PGIMS Rohtak cancer facility remains non-functional for over three years

The centre brings together comprehensive cancer care services under one roof, including surgical oncology, medical oncology, radiation oncology, bone marrow transplant, paediatric oncology, preventive oncology, nuclear medicine and theranostics, onco-pathology, and palliative care. It is also equipped to perform complex oncological surgeries supported by advanced operation theatre infrastructure and specialised surgical teams.

Additionally, the facility is strengthened by advanced diagnostic and treatment technologies such as AI-powered PET-CT imaging and high-precision radiotherapy systems, designed to improve accuracy in cancer detection, staging, and treatment delivery. The centre also offers immunotherapy, an advanced treatment approach that enhances the body’s immune system to recognise and fight cancer cells more effectively. 

Speaking at the launch, Dr. S. Rajasundaram, CEO, Iswarya Hospital, said, “Cancer continues to be one of the most significant health challenges in India today. According to the Indian Council of Medical Research and the National Cancer Registry Programme, new cancer cases are projected to rise to around 15.7 lakh cases by 2025, with breast, lung, and oral cancers remaining among the most commonly diagnosed cancers in the country. Breast cancer alone is expected to account for more than two lakh new cases annually, making it the leading cancer among Indian women,” reports Chennai Online.

He added that late diagnosis remains one of the biggest challenges, significantly affecting survival outcomes. The introduction of AI-powered PET-CT technology and precision radiotherapy at the centre will enable earlier detection, more accurate assessment of disease spread, and improved treatment planning.

Speaking to Chennai Online, Dr. Arun Muthuvel, Managing Director, Iswarya Hospital, said, “At Iswarya, our focus has always been on combining advanced technology with compassionate care. The launch of the Iswarya Cancer Centre represents a major milestone in expanding our oncology services. By bringing together expert specialists, complex cancer surgery capabilities, advanced imaging technologies, immunotherapy, and integrated treatment facilities under one roof, we aim to deliver comprehensive cancer care that patients can trust. Early detection and timely treatment are critical to improving outcomes.”

The AI-powered PET-CT scan available at the centre combines advanced imaging with artificial intelligence-driven analysis, enabling clinicians to detect cancer earlier, monitor treatment response more effectively, and design personalised treatment plans.

Also Read:Rs 1000 crore cancer hospital, medical colleges to come up at Hamirpur Medical College

With the launch of the Iswarya Cancer Centre at OMR Taramani, the hospital aims to provide timely diagnosis, advanced treatment options, and multidisciplinary cancer care for patients across Chennai and surrounding regions.
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News